Haemonetics splits with Zimmer
This article was originally published in The Gray Sheet
Executive Summary
Haemonetics Corp. will end its five-year U.S. distribution agreement with Zimmer for the OrthoPAT blood management system, the company announces Aug. 30. Haemonetics, which already sells OrthoPAT directly in Europe and Asia, will expand its sales and services operations to accommodate the extended U.S. customer base once Zimmer's distribution rights end in February 2006. Zimmer will pursue internal and external development of new blood salvage technologies...